FluoGuide
PublicFluoGuide is now publicly traded
The data on this page reflects FluoGuide's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
May 7, 2019
Last Round
Follow-on Offering
Jun 18, 2024
Est. Valuation at Exit
$55.45M
Total Funding Raised
$26.78M
Company Overview
FluoGuide has raised $26.78M. It was founded in 2018.
FluoGuide A/S, founded in 2018, is a publicly-traded Danish biotechnology company focused on improving surgical outcomes for cancer patients. The company's primary business is the development of its lead product, FG001, which is designed to make cancer cells fluorescent during surgery, thereby enabling surgeons to more accurately identify and remove malignant tissue. This technology aims to reduce cancer recurrence and surgical complications. FluoGuide is in the clinical trial phase, with studies underway for aggressive brain cancer (glioblastoma), head and neck cancer, and lung cancer. The company is listed on the Nasdaq First North Growth Market in Sweden and has entered into strategic partnerships with MedTech companies like Olympus to advance its technology.
Verticals
Oncology, Medical Imaging, Surgical Technology
AI Layer
Non-AI
FluoGuide Comparables
Compare FluoGuide with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheraFluor, Inc. | 79% | |
| 五稜化薬株式会社 | 78% | |
| Perfusion Tech ApS | 57% |
For institutional investors. Book with your work email.
FluoGuide Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jun 18, 2024 | ||||
| Follow-on Offering | Dec 8, 2023 | ||||
| Follow-on Offering | Jul 5, 2023 | ||||
| Grant | Mar 21, 2023 | ||||
| Follow-on Offering | Mar 10, 2022 | ||||
Follow-on Offering | May 11, 2021 |
For institutional investors. Book with your work email.
FluoGuide Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Life Science Invest Fund 1 | Follow-on Offering |
FluoGuide Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.